Sponsored Links
| Tocagen's First-in-Human Clinical Trial Of Toca 511 Enrolling Patients With High Grade Glioma |
 |
 |
 |
| Medical News - Eye Health | |||
|
Tocagen Inc. announced the company is enrolling patients with recurrent high grade glioma, such as those with glioblastoma multiforme (GBM, Grade 4), in its first-in-human clinical trial of Toca 511... Read more: Eye Health / Blindness News From Medical News Today
|